Actionable insights straight to your inbox

Equities logo

A Look at Pharma M&A — Consolidating Strengths In Oncology, Immunology and More

There's been significant M&A in fighting cancer and rare diseases — as companies seek strategic dominance in defined areas.
On Tuesday, we saw one of those post three-day weekend rallies, which seemed to have come to a halt as of yesterday, as Euro woes continue to dominate. I'm staring at the screen seeing a 1.69